Purchase Order 36C25723P0101
Award Date
1/1/23
Potential Completion Date
12/31/23
Potential Value
$866K
Federal Agency
Veterans Integrated Service Network 17
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,172,834.00 firm-fixed-price delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical PYLARIFY F-18 DCFPYL, a molecular diagnostic for prostate cancer detection. The contract has a period of performance through May 31, 2025. Sofie CO. is an experienced prime contractor providing radiopharmaceuticals,...
This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract, valued at $2,363,711.60, is for the ordering of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The contract has a period of performance through December 31, 2025 and is a firm fixed-price contract. Sofie is an established supplier of...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging...
The Department of Veterans Affairs Veterans Health Administration awarded a $1.37 million firm fixed price purchase order to Sofie CO., doing business as Sofie, for the delivery of Pylarify radiopharmaceutical isotopes for prostate cancer patients. The contract supports the Special Notice published by VA Network Contracting Office 2 announcing sole source award to Progenics Pharmaceuticals, Inc. through their distributor Sofie. The award aims to provide Pylarify, a prostate-specific membrane...
The Department of Veterans Affairs (VA) awarded a $1,198,895.04 firm fixed-price purchase order contract to Sofie CO., a small business prime contractor, for the purchase and delivery of the radiopharmaceutical PYLARIFY (Piflufolastat F-18 Injection) over a one-year period. This contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 5 for radiology services at the DC VA Medical Center. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is an...